Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SRPK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MIR7703 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BUB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CXorf23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POU2F2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
JADE3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL13RA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPS15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGAP21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
N4BP2L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FGFR1OP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM102B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WIPF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NT5C3A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UGGT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TES - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTUS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on